jan gerstoft
jan gerstoft
professor clinical virology, University of Copenhagen
Verified email at rh.dk
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20202003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
13982006
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ...
Jama 316 (2), 171-181, 2016
11552016
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10482008
Survival of persons with and without HIV infection in Denmark, 1995–2005
N Lohse, ABE Hansen, G Pedersen, G Kronborg, J Gerstoft, HT Sørensen, ...
Annals of internal medicine 146 (2), 87-95, 2007
9812007
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
6782018
A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
TN Kledal, MM Rosenkilde, F Coulin, G Simmons, AH Johnsen, S Alouani, ...
Science 277 (5332), 1656-1659, 1997
5721997
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
4842014
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin
P Garred, HO Madsen, U Balslev, BO Hofmann, C Pedersen, J Gerstoft, ...
The Lancet 349 (9047), 236-240, 1997
4831997
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of …
AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ...
The Lancet 393 (10189), 2428-2438, 2019
4432019
Mortality attributable to smoking among HIV-1–infected individuals: a nationwide, population-based cohort study
M Helleberg, S Afzal, G Kronborg, CS Larsen, G Pedersen, C Pedersen, ...
Clinical Infectious Diseases 56 (5), 727-734, 2013
4382013
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study
HJ Stellbrink, C Orkin, JR Arribas, J Compston, J Gerstoft, ...
Clinical Infectious Diseases 51 (8), 963-972, 2010
4202010
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study
N Obel, HF Thomsen, G Kronborg, CS Larsen, PR Hildebrandt, ...
Clinical Infectious Diseases 44 (12), 1625-1631, 2007
3932007
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ...
Journal of viral hepatitis 21, 5-33, 2014
3502014
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus …
M Sulkowski, C Hezode, J Gerstoft, JM Vierling, J Mallolas, S Pol, ...
The Lancet 385 (9973), 1087-1097, 2015
3432015
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults
E DeJesus, G Herrera, E Teofilo, J Gerstoft, CB Buendia, JD Brand, ...
Clinical infectious diseases 39 (7), 1038-1046, 2004
3222004
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
J Eugen-Olsen, AKN Iversen, P Garred, U Koppelhus, TL Benfield, ...
Aids 11 (3), 305-310, 1997
2721997
Clinical course of primary HIV infection: consequences for subsequent course of infection.
C Pedersen, BO Lindhardt, BL Jensen, E Lauritzen, J Gerstoft, ...
British Medical Journal 299 (6692), 154-157, 1989
2691989
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2612005
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ...
Journal of viral hepatitis 21, 60-89, 2014
2462014
The system can't perform the operation now. Try again later.
Articles 1–20